Market research
1466.HK Affluent Partners Holdings Limited
HK HKD Consumer Cyclical
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 1B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- -0.32
Profile
Company facts
- Exchange
- HK
- Currency
- HKD
- Sector
- Consumer Cyclical
- Industry
- Luxury Goods
- ISIN
- KYG0130B1014
- Market cap
- 1B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- -0.32
About
About Affluent Partners Holdings Limited
Baijin Life Science Holdings Limited, together with its subsidiaries, engages in the procurement, processing, design, production, and wholesale distribution of pearls and fine jewelry products in Hong Kong, the People's Republic of China, the United States, and internationally. It operates through three segments: Jewellery Business, Skincare Business, and Strategic Investment. The company is involved in the research and development of cellular and large molecule drugs; clinical research services; research, development, and sale of medical devices, cosmetics, and private care products under the FO brand name; and provision of scientific research, franchise licensing, and consultation services. It also engages in real estate financial assets investments; provision of skincare services; and supply chain management. The company was formerly known as Affluent Partners Holdings Limited and changed its name to Baijin Life Science Holdings Limited in December 2024. Baijin Life Science Holdings Limited was incorporated in 2014 and is based in Wan Chai, Hong Kong.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 1466.HK discussion.
5 years, 5 months ago
Affluent Partners Holdings Limited is currently in a long term downtrend where the price is trading 1.8% below its 200 day moving average.
From a valuation standpoint, the stock is 91.7% cheaper than other stocks from the Consumer Cyclical sector with a price to sales ratio of 0.4.
Affluent Partners Holdings Limited's total revenue sank by 56.0% to $28M since the same quarter in the previous year.
Its net income has dropped by 155.4% to $-70M since the same quarter in the previous year.
Finally, its free cash flow fell by 104.7% to $-322K since the same quarter in the previous year.
Based on the above factors, Affluent Partners Holdings Limited gets an overall score of 1/5.